Pages that link to "Q38333373"
Jump to navigation
Jump to search
The following pages link to In vitro DNA tethering of HIV-1 integrase by the transcriptional coactivator LEDGF/p75. (Q38333373):
Displaying 19 items.
- The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy (Q26849265) (← links)
- Novel therapeutic strategies targeting HIV integrase (Q27003960) (← links)
- Small Molecule Inhibitors of the LEDGF Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design (Q27670782) (← links)
- Structural basis for high-affinity binding of LEDGF PWWP to mononucleosomes (Q27676304) (← links)
- Interrogating HIV integrase for compounds that bind- a SAMPL challenge (Q27681778) (← links)
- LEDGF/p75-independent HIV-1 replication demonstrates a role for HRP-2 and remains sensitive to inhibition by LEDGINs (Q34186964) (← links)
- Understanding lentiviral vector chromatin targeting: working to reduce insertional mutagenic potential for gene therapy. (Q34484917) (← links)
- HIV-1 IN/Pol recruits LEDGF/p75 into viral particles (Q35170009) (← links)
- Repair of oxidative DNA base damage in the host genome influences the HIV integration site sequence preference. (Q35211024) (← links)
- Role of the PWWP domain of lens epithelium-derived growth factor (LEDGF)/p75 cofactor in lentiviral integration targeting (Q35842252) (← links)
- The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance (Q37288671) (← links)
- HIV Drug Resistance and the Advent of Integrase Inhibitors. (Q38062462) (← links)
- Small-molecule inhibitors of the LEDGF/p75 binding site of integrase block HIV replication and modulate integrase multimerization (Q39337204) (← links)
- Dynamic Oligomerization of Integrase Orchestrates HIV Nuclear Entry (Q40457748) (← links)
- LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions (Q41454699) (← links)
- Lens epithelium-derived growth factor/p75 qualifies as a target for HIV gene therapy in the NSG mouse model. (Q42016614) (← links)
- Monitoring the HIV-1 integrase enzymatic activity using atomic force microscopy in a 2LTR system (Q46545766) (← links)
- Structure, mechanics, and binding mode heterogeneity of LEDGF/p75–DNA nucleoprotein complexes revealed by scanning force microscopy (Q57937336) (← links)
- Impact of LEDGIN treatment during virus production on residual HIV-1 transcription (Q64086928) (← links)